Clinical Trial: Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients

Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational

Official Title: Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients

Brief Summary: Using to method of Proteomics, for aims to conquer intractable disease, try to access variety experiment. Biomarker is necessary to develop new diagnosis method and target of treatment.

Detailed Summary: Following Seoul National University Hospital Institutional Review Board approval, obtain serum and platelet with neurodegeneration patients and control group visited the part of neurology, there'll be analysis to differentiate each other diseases use to method Proteomics. Biomarker will be screening via 1D/2D analysis, Mass analysis, database searching- the MASCOT search tool, SWISS-PROT and etc.
Sponsor: Seoul National University Hospital

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Seoul National University Hospital

Dates:
Date Received: March 11, 2012
Date Started: May 2005
Date Completion:
Last Updated: April 14, 2016
Last Verified: March 2016